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Abstract 22 
 23 
Burkholderia cenocepacia infects patients with cystic fibrosis. We have previously shown that B. 24 
cenocepacia can survive in macrophages within membrane vacuoles (BcCVs) that preclude 25 
fusion with the lysosome. The bacterial factors involved in B. cenocepacia intracellular survival 26 
are not fully elucidated. We report here that deletion of BCAM0628, encoding a predicted low-27 
molecular weight protein tyrosine phosphatase (LMW-PTP) that is restricted to B. cenocepacia 28 
strains of the transmissible ET-12 clone, accelerates the maturation of the BcCVs. Compared to 29 
parental strain and deletion mutants in other LMW-PTPs that are widely conserved in 30 
Burkholderia species, a greater proportion of BcCVs containing the ∆BCAM0628 mutant were 31 
targeted to the lysosome. Accelerated BcCV maturation was not due to reduced intracellular 32 
viability since ∆BCAM0628 survived and replicated in macrophages similarly to the parental 33 
strain. Therefore, BCAM0628 was referred to as dpm (delayed phagosome maturation). We 34 
provide evidence that the Dpm protein is secreted during growth in vitro and upon macrophage 35 
infection. Dpm secretion requires an N-terminal signal peptide. Heterologous expression of Dpm 36 
in B. multivorans confers to this bacterium a similar phagosomal maturation delay as found with 37 
B. cenocepacia. We demonstrate that Dpm is an inactive phosphatase, suggesting that its 38 
contribution to phagosomal maturation arrest must be unrelated to tyrosine phosphatase activity.  39 
40 
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INTRODUCTION 41 
 42 
The Burkholderia cepacia complex (Bcc) is a diverse group of at least 17 species widely 43 
distributed in the environment (Lipuma, 2005). Bcc species display extraordinary metabolic 44 
versatility and have the ability to colonize and adapt to various ecological niches (Coenye & 45 
Vandamme, 2003). Bcc strains are potentially beneficial bacteria to promote plant growth, pest 46 
control, and bioremediation (Parke & Gurian-Sherman, 2001). Unfortunately, Bcc are also 47 
opportunistic pathogens causing chronic infection in immunocompromised individuals such as 48 
those with chronic granulomatous disease and cystic fibrosis (Loutet & Valvano, 2010; 49 
Mahenthiralingam et al., 2001; Vandamme et al., 1997). Burkholderia cenocepacia and 50 
Burkholderia multivorans are the two Bcc species most commonly isolated worldwide from 51 
cystic fibrosis patients (Drevinek & Mahenthiralingam, 2010; Govan et al., 2007). 52 
 53 
Chronic infection with B. cenocepacia can result in acute, fatal necrotizing pneumonia and 54 
septicemia, termed “cepacia syndrome” (Courtney et al., 2004; Mahenthiralingam et al., 2008). 55 
Due to their intrinsic resistance to most available antibiotics the treatment of Burkholderia 56 
infections becomes difficult (George et al., 2009; Waters & Ratjen, 2006). Macrophages are 57 
crucial in the early stage of host defense against infections; they ingest and destroy incoming 58 
pathogens upon phagocytosis and recruit inflammatory cells to the site of infection (Hume et al., 59 
2002; Kinchen & Ravichandran, 2008). Previous work has demonstrated that B. cenocepacia 60 
survive within a membrane-bound vacuole (hereafter referred as BcCV) in amoebae, human 61 
respiratory epithelial cells (Marolda et al., 1999; Saldias & Valvano, 2009) and macrophages 62 
(Hamad et al., 2010; Lamothe et al., 2007). Intramacrophage survival of B. cenocepacia has 63 
been associated with an arrest of the phagosomal maturation, since the BcCV shows impaired 64 
acidification and delayed fusion with lysosomes during the initial 6-8 h post infection (Huynh et 65 
al., 2010; Lamothe et al., 2007; Lamothe & Valvano, 2008). The delayed fusion of the BcCV 66 
with lysosomes can be attributed, at least in part, to impaired assembly of the NADPH oxidase 67 
complex on the BcCV membrane (Keith et al., 2009) as consequence of Rac1 inactivation 68 
(Flannagan et al., 2012; Rosales-Reyes et al., 2012b). Inactivation of Rab7 (Huynh et al., 2010), 69 
a small GTPase important for the endosome maturation (Wang et al., 2011), is also critical for 70 
this delay. Furthermore, recent evidence indicates that the BcCV can lose membrane integrity 71 
resulting in bacteria coming into contact with cytosol components (Al-Khodor et al., 2013) and 72 
promoting macrophage cell death by pyroptosis (Rosales-Reyes et al., 2012a). Loss of BcCV 73 
permeability partly depends on the activity of a type VI secretory system, while effector proteins 74 
secreted by a Type II secretory pathway can alter the BcCV maturation (Rosales-Reyes et al., 75 
2012a). These observations suggest a complex interplay of B. cenocepacia effectors contributed 76 
by at least two different secretory pathways in the manipulation of the vesicular trafficking in 77 
macrophages. However, the specific bacterial components required are largely unknown. 78 
 79 
Protein tyrosine phosphorylation is a covalent modification that regulates numerous cellular 80 
functions in eukaryotic and bacterial cells (Cozzone et al., 2004). Bacterial tyrosine kinases 81 
catalyze the phosphorylation of the side hydroxyl groups of tyrosine residues in protein 82 
substrates leading to the formation of the corresponding phosphomonoesters (Shi et al., 1998), 83 
while bacterial protein tyrosine phosphatases (PTPs) catalyze the reverse reaction. Bacterial 84 
PTPs can be categorized based on structural basis into three subfamilies: (i) the low molecular 85 
weight protein-tyrosine phosphatases (LMW-PTPs), composed by small and acidic enzymes 86 
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present also in eukaryotes; (ii) the classic type I Cys-based PTPs, also known as eukaryotic-like 87 
phosphatases (Böhmer et al., 2013); and (iii) the polymerase and histidinol phosphatase family 88 
of phosphoesterases, which is found mainly in Gram-positive bacteria (Morona et al., 2002). 89 
Bacterial PTPs operate in two major processes: production and translocation of 90 
exopolysaccharides (reviewed in (Cozzone et al., 2004)), and interference with host signal 91 
transduction upon infection (Cozzone, 2005; Whitmore & Lamont, 2012). Examples of PTPs 92 
affecting host signaling pathways include YopH from Yersinia, which is injected into human 93 
epithelial cells where it targets host focal adhesion proteins, such as p130Cas, paxillin, and focal 94 
adhesion kinase (FAK) (Black & Bliska, 1997; Persson et al., 1997). Similarly, SptP from 95 
Salmonella enterica serovar Typhimurium inhibits the activation of the MAPK pathway by 96 
dephosphorylating Raf (Lin et al., 2003), disrupts the intermediate filaments distribution after 97 
vimentin binding (Murli et al., 2001), and regulates the biogenesis of an intracellular niche 98 
through VCP dephosphorylation (Humphreys et al., 2009). Mycobacterium tuberculosis secretes 99 
two PTPs, both required for intracellular survival in macrophages. PtpA inhibits V-ATPase 100 
trafficking to the mycobacterial phagosome and blocks phagolysosome fusion (Bach et al., 2008; 101 
Wong et al., 2011), while PtpB has a possible role subverting the host immune response (Zhou et 102 
al., 2010). 103 
 104 
Manipulation of host signal transduction pathways by intracellular B. cenocepacia strongly 105 
suggests that bacterial secreted virulence factors are operating to allow the subversion of the host 106 
cell (Abdulrahman et al., 2013; Rosales-Reyes et al., 2012a). On this basis, we evaluated four 107 
predicted LMW-PTPs: BCAM0208, BCAM0628, BceD and BCAL2200, for their contribution 108 
to intracellular survival and phagosome maturation arrest. We demonstrate that B. cenocepacia 109 
secretes BCAM0628 (herein designated as dpm (delayed phagosome maturation) during growth 110 
and upon macrophage infection. Deletion of dpm accelerates the maturation of the BcCVs. 111 
Translocation of Dpm requires an N-terminal signal peptide plus an unperturbed C-terminal 112 
region. We also demonstrate that Dpm is an inactive phosphatase, suggesting that the maturation 113 
arrest of phagocytic vacuoles is unrelated to tyrosine phosphatase activity.  114 
 115 
 116 
METHODS 117 
 118 
Bacterial strains, plasmids and growth conditions. Bacterial strains and plasmids used here 119 
are listed in Table 1. Bacteria were cultured in Luria broth (LB; Difco) at 37 °C with shaking. 120 
Escherichia coli cultures were supplemented, as required, with the following antibiotics (final 121 
concentrations): tetracycline (25 µg ml–1), kanamycin (40 µg ml−1), trimethoprim (50 µg ml−1) 122 
and chloramphenicol (30 µg ml–1). B. cenocepacia cultures were supplemented, as required, with 123 
trimethoprim (100 µg ml−1), tetracycline (100 µg ml−1), and chloramphenicol (120 µg ml–1). To 124 
assess growth rates of parental and mutant strains of B. cenocepacia MH1K, overnight cultures 125 
were inoculated into fresh medium to give a starting optical density at 600 nm (OD600) of 0.01. 126 
Growth rates were determined in 100-well microtiter plates using a Bioscreen C automated 127 
microbiology growth curve analysis system (MTX Lab Systems, Inc.). E. coli strains for cloning 128 
and production of recombinant proteins were DH5α and BL21(DE3), respectively. E. coli GT115 129 
was used for cloning into the suicide vector pGPI-SceI. 130 
 131 
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General molecular techniques. DNA manipulations and cloning were performed as described 132 
previously (Sambrook & Russell, 2001). PCR amplification was performed using Taq or HotStar 133 
HiFidelity DNA polymerases (Qiagen). Antarctic phosphatase (New England Biolabs), 134 
restriction enzymes (New England Biolabs) and T4 DNA ligase (Roche Applied Science) were 135 
used as recommended by the manufacturers. DNA sequencing was completed at the sequencing 136 
facility in York University (Toronto, Canada) and in Eurofins MWG Operon (Alabama, USA). 137 
Plasmids were mobilized into B. cenocepacia and B. multivorans by triparental mating (Craig et 138 
al., 1989; Figurski & Helinski, 1979).  139 
 140 
Mutagenesis of B. cenocepacia K56-2. The construction of unmarked, non-polar mutant strains 141 
was accomplished as described (Flannagan et al., 2008). The deletion mutagenesis plasmids 142 
were created by amplifying 400-550 bp DNA fragments flanking the corresponding target genes 143 
using chromosomal DNA from B. cenocepacia K56-2 as template and the indicated primer pairs 144 
(Table 2). The amplicons were double digested with the corresponding restriction enzymes 145 
(Table 2) and cloned into pGPISce-I resulting in mutagenic plasmids pDelM0208, pDelM0628, 146 
pDelM0857 and pDelL2200 (Table 1). Mutagenic plasmids were mobilized into B. cenocepacia 147 
MH1K strain by triparental mating and co-integrants were selected using 100 µg ml−1 148 
trimethoprim. Selection against the E. coli donor and helper strains after the triparental mating 149 
was accomplished using 100 µg ml−1 ampicillin in combination with 25 µg ml−1 polymyxin B. 150 
pDAI-Sce-I-SacB, used in the final stage of mutagenesis to induce the second recombination 151 
event leading to an unmarked gene deletion, was mobilized into B. cenocepacia co-integrants. 152 
Exconjugants were selected with 100 µg ml−1 tetracycline, 100 µg ml−1 ampicillin, and 25 µg 153 
ml−1 polymyxin B. Identification of the appropriate gene deletions was accomplished by PCR. 154 
Deletion mutants were cured of the levansucrase (SacB)-encoding plasmid by growing the B. 155 
cenocepacia mutant strains in LB broth overnight and then plating on LB agar supplemented 156 
with 5% (w/v) sucrose. 157 
 158 
Motility assays. For swimming assays, 2 µl of overnight culture, adjusted to an OD600 of 1.0, 159 
was inoculated within the agar of a swim plate (LB; 0.3% agar). For swarming assays, 2 µl of 160 
overnight culture, adjusted to an OD600 of 1.0, was spotted on top of the swarm plate agar 161 
(nutrient broth; 0.5% agar, 0.2% glucose). The plates were incubated at 37 °C for 24 h, after 162 
which the diameters of the swimming and swarming zones were measured. 163 
 164 
Cloning of predicted phosphotyrosine phosphatase genes and site-directed mutagenesis. 165 
The open reading frames BCAM0208, bceD, BCAL2200 and the full length dpm or the dpm 166 
truncated version were PCR-amplified using chromosomal DNA from B. cenocepacia K56-2 as 167 
template with the corresponding primer pairs (Table 2). Amplicons were digested with the 168 
restriction enzymes NdeI-XbaI and cloned into a similarly digested pDA17 plasmid, giving rise 169 
to pM0208, pbceD, pL2200, pdpm and p∆27 (Table 1). To produce histidine tagged recombinant 170 
proteins, Dpm and BCAL2200 the plasmids pdpm or pL2200 were digested with NdeI-HindIII 171 
and the resulting inserts were cloned into a similarly digested pET28a plasmid, giving rise to 172 
pHisdpm and pHisL2200, respectively. To generate pdpmHis, dpm was amplified from 173 
chromosomal DNA with the primer pair 6829-6830 (Table 2), the PCR product was digested 174 
with NcoI-XhoI and cloned into a similarly digested pET28a. The site directed mutagenesis of 175 
dpm was performed by PCR with Pfu DNA polymerase (Stratagene) using the primer pair 6496-176 
6517 (Table 2) and the plasmid pHisdpm or pdpmHis as template for the reaction. DpnI was 177 
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added to PCR reactions for overnight digestion of parental plasmid DNA at 37 °C. The resulting 178 
DNA was introduced into E. coli DH5α by transformation, and transformants were selected on 179 
LB-agar containing 40 µg ml-1 kanamycin. Directed mutagenesis in the resulting plasmids, 180 
pHisdpm D36C and pdpmHis D36C (Table 1), respectively, was confirmed by sequencing. 181 
 182 
Protein analysis. Overnight cultures were diluted 1:100 in 7 ml of LB. After 2 h of incubation at 183 
37 °C, the cultures were centrifuged for 15 min at 16,100 ×g and the resulting pellets were 184 
resuspended in 1× SDS–PAGE sample buffer; the volume was normalized to the OD600. 185 
Supernatants were sterilized through a 0.22-µm filter (Millipore), and proteins were precipitated 186 
during 4 h at 4 °C with 10% (vol/vol) of trichloroacetic acid (final concentration). The 187 
precipitates were isolated by centrifugation at 16,100 ×g for 30 min at 4 °C, and the pellet was 188 
air-dried and resuspended in 2× SDS–PAGE sample buffer containing 10% (vol/vol) of saturated 189 
Tris base. Protein concentration of the different cultures was normalized to the OD600 value. 190 
After SDS–PAGE, the gel was transferred onto a nitrocellulose membrane. The membrane was 191 
then blocked overnight with western blocking reagent (Roche Diagnostics) in TBST (50 mM 192 
Tris-HCl pH 7.5, 150 mM NaCl, 0.1 % Tween-20). The primary antibodies, anti-FLAG M2 193 
monoclonal antibody (Sigma) or anti-αRNAPol (E. coli) (Neoclone), were diluted to 1:15,000 in 194 
TBST, anti-beta lactamase (TEM-1, E. coli) (Thermo Fisher) was diluted to 1:5,000 in TBST. 195 
Primary antibodies were applied for 1.5 h. Secondary antibody, goat anti-mouse Alexa Fluor 680 196 
IgG antibodies (Invitrogen), was diluted to 1:15,000 and applied for 1 h. Western blots were 197 
developed using LI-COR Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE). 198 
 199 
Intracellular survival in macrophages. Bacterial intracellular survival in RAW264.7 murine 200 
macrophages was assayed as described previously (Schmerk & Valvano, 2013). Bacteria were 201 
added to macrophages at multiplicity of infection (MOI) of 50. Plates were centrifuged for 1 min 202 
at 300 × g and incubated for 2 h at 37 °C under 5% CO2. Infected macrophages were washed 203 
with PBS three times to remove extracellular bacteria and fresh medium containing 100 µg ml−1 204 
gentamicin was added to kill any remaining extracellular bacteria. After 1 h, the macrophages 205 
were washed twice in PBS, and fresh medium containing 10 µg ml−1 gentamicin was added for 206 
the remainder of the experiment. To enumerate intracellular bacteria infected macrophages were 207 
lysed with 0.1% sodium deoxycholate (w/v), and the lysates were serially diluted in PBS before 208 
plating on LB agar. 209 
 210 
Phagosomal maturation assays. For lysosome labeling, macrophages were incubated overnight 211 
with 250 µg ml−1 fluorescein isothiocyanate–dextran (Invitrogen). External fluorescein–dextran 212 
was removed by serial washes with PBS and chased for 1 h in fresh medium. Infections of 213 
RAW264.7 macrophages with B. cenocepacia strains carrying pIN62 (for bacteria labeling) or B. 214 
multivorans ATCC 17616 Gms carrying pDA17 or pdpm were performed as described above. 215 
After infection extracellular bacteria were removed by washes and fresh medium containing 50 216 
µg ml−1 gentamicin was added. At 2 h post infection cells were fixed at room temperature for 25 217 
min using 4% (v/v) paraformaldehyde and visualized at × 100 magnification. The B. multivorans 218 
infected macrophages were similarly treated but the infection proceeded during 1 h, similarly to 219 
(Schmerk & Valvano, 2013). For immunostaining, fixed cells were permeabilized using 0.1% 220 
(v/v) Triton X-100 at room temperature for 30 min. Coverslips were blocked in a solution of 3% 221 
(w/v) BSA, 2% (v/v) FBS in PBS for 2 h at 4 °C. The coverslips were then incubated at 4 °C 222 
overnight with rat anti-lysosome-associated membrane protein-1 (LAMP-1) (clone 1D4B; BD 223 
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Pharmingen) at a 1:200 dilution, for complementation assays due to plasmid incompatibly 224 
bacteria were labeled with rabbit antiserum against B. cenocepacia K56-2 (Rosales-Reyes et al., 225 
2012b) at a 1:4 000 dilution. Alexa Fluor 488-labelled chicken anti-rat (Invitrogen) and Alexa 226 
Fluor 594-labelled goat anti-rabbit (Invitrogen), when necessary, were added at a 1:4 000 227 
dilution for 90 min prior to visualization at × 100 magnification. Fluorescence and phase-contrast 228 
images were acquired using a QImaging RETIGA-SRV camera on an Axioscope 2 (Carl Zeiss) 229 
microscope. 230 
 231 
Intramacrophage Dpm secretion. RAW264.7 macrophages were infected with B. cenocepacia 232 
∆dpm strain carrying the plasmid pdpm or p∆27 (Table 1) as described above. At 1 h post 233 
infection cells were fixed and treated as described for immunostaining. The coverslips were then 234 
incubated at 4 °C overnight with mouse anti-FLAG M2 monoclonal antibody (Sigma) at a 1:200 235 
dilution and with rabbit antiserum against B. cenocepacia K56-2 at a 1:4 000 dilution. Then 236 
Alexa Fluor 488-labelled goat anti-mouse (Invitrogen) and Alexa Fluor 594-labelled goat anti-237 
rabbit (Invitrogen) were added at a 1:4 000 dilution for 90 min prior to visualization at × 100 238 
magnification. 239 
 240 
Production and purification of recombinant proteins. Plasmids pHisdpm, pHisL2200 and 241 
pdpmHis (Table 1) were expressed in E. coli BL21(DE3). 200 ml LB cultures were growth at 242 
30°C until they reached an OD600 0.7. Then 0.3 mM IPTG (isopropyl-β-D-243 
thiogalactopyranoside) was added and bacteria continued growing for 4 h. Induced bacteria were 244 
harvested by centrifugation and bacterial pellets were resuspended in binding buffer, BB (20 mM 245 
Tris–HCl, pH 8.0, 0.5 M NaCl) containing protease inhibitor cocktail (Roche Diagnostics). Cell 246 
lysis was achieved using a cell disruptor (Constant Systems Ltd) at 20 kpsi. Lysates were 247 
centrifuged for 50 min at 24,000 ×g, 4 °C, to pellet undisrupted cells and inclusion bodies. 248 
Soluble fractions were applied to Ni2+ charged sepharose beads for 30 min at 4 °C. After 249 
extensive washing with BB containing 40 mM imidazole, proteins were eluted with BB 250 
containing 200 mM imidazole. Purified recombinant proteins were dialyzed overnight at 4 °C 251 
against 1.0 l of TND buffer (50 mM Tris–HCl, pH 8.0, 100 mM NaCl and 1 mM DTT). Protein 252 
concentration was determined by using the Bio-Rad protein assay dye-binding reagent (Bio-253 
Rad). 254 
 255 
Phosphatase activity. Phosphatase activity was determined by monitoring, at 405 nm, the p-256 
nitrophenol (PNP) formed from p-nitrophenol phosphate (PNPP) as previously described in 257 
(Cowley et al., 2002) with minor modifications. Mixtures reaction contained, in a final volume 258 
of 1 ml, 2.5 µg of purified and dialyzed protein in 7 mM HEPES pH 7.0, 5 mM MgCl2 and 1 259 
mM DTT. Enzymatic reactions were started adding 1 mM PNPP and incubated at 37 °C. After 260 
the determinate time intervals reactions were stopped adding 0.2 N NaOH (final concentration) 261 
and the absorbance was measured at 405 nm. The concentration of PNP formed was estimated 262 
using a molar extinction coefficient of 1.78 ×104 M−1 cm −1. And phosphatase activity was 263 
calculated from the slope obtained in time course analyses. 264 
 265 
Statistical analyses. All experiments were performed at least in triplicate. All data are presented 266 
as means ± SEM of the indicated number of experiments. Statistical analyses were done by 267 
Student’s t-test and one-way analysis of variance for comparisons of means using GraphPad 268 
Prism version 4.03. 269 
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 270 
 271 
RESULTS 272 
 273 
Identification of B. cenocepacia putative LMW-PTPs 274 
Analysis of the B. cenocepacia J2315 genome (J2315 is clonally related to strain K56-2) with 275 
Conserved Domain Database (Marchler-Bauer et al., 2011) tools revealed 4 open reading frames 276 
encoding proteins with putative LMWPc domains (pfam01451). These enzymes catalyze the 277 
removal of a phosphate group attached to a tyrosine residue, using a cysteinyl-phosphate enzyme 278 
intermediate (Wang et al., 2000). The predicted LMW-PTPs were BCAL2200, BCAM0208, 279 
BCAM0628 (Dpm) and BCAM0857 (BceD). The genes encoding these proteins are located in 280 
different clusters within the first (BCAL) and second (BCAM) chromosomes (Fig. 1). The 281 
cluster containing bceD was previously identified as part of the bce exopolysaccharide 282 
biosynthetic gene cluster (Moreira et al., 2003), which is widespread within all the sequenced 283 
Burkholderia strains, with the exception of B. rhizoxinica and B. mallei (Ferreira et al., 2010). 284 
BCAM0208 resides in another exopolysaccharide biosynthesis cluster next to the predicted 285 
tyrosine kinase BCAM0207 (Fig. 1b), in a similar arrangement as the described bceD/bceF pair 286 
of genes (Moreira et al., 2003). BCAM0208/BCAM0207 are also widespread in the 287 
Burkholderia genus. BCAL2200 is located within a region highly conserved in other 288 
Burkholderia species, which presumably is involved in regulating sulfur amino acid metabolism 289 
(Fig. 1b and data not shown). In contrast, dpm is located in a poorly conserved region of the 290 
genome, and homologues to dpm are only found in B. cenocepacia J2315, K56-2, and H111, as 291 
well as in B. cepacia GG4 and B. lata (Fig. 1b and data not shown). Analysis of the translated 292 
sequences of B. cenocepacia LMW-PTPs showed a common secondary structure prediction 293 
pattern (data not shown) and indicated that all except Dpm have the conserved amino acids of the 294 
tyrosine phosphatase motif, CX5R(S/T) (Fig. 1a). Dpm has an aspartate substitution in the 295 
position of the catalytic cysteine (Fig. 1a) and a larger N-terminus with strong prediction to a 296 
signal peptide sequence (data not shown), suggesting it is a secreted protein. 297 
 298 
Dpm is secreted to the growth medium 299 
The genes encoding BCAM0208, Dpm, BceD and BCAL2200 were cloned into pDA17 under 300 
the expression of the constitutive dhfr promoter. Resulting plasmids, pM0208, pdpm, pbceD and 301 
pL2200 (Table 1) were mobilized into B. cenocepacia K56-2 and secretion assays were 302 
performed as described in Methods. The pDA17 vector enables to fuse a C-terminal FLAG tag, 303 
which facilitates detection of the expressed products by immunoblotting. Our results show that 304 
except for BceD, the other proteins had similar expression levels (Fig. 2, upper left panel), as 305 
compared to the β-lactamase TEM-1, which was used as a loading control (Fig. 2, lower left 306 
panel). However, only Dpm was found in the supernatant (Fig. 2, upper panels). The absence of 307 
TEM-1 in supernatants (Fig. 2, lower panels) rules out spontaneous cell lysis or outer membrane 308 
leakage, confirming that Dpm is a secreted protein. Also, we did not find cytoplasmic RNA 309 
polymerase α-subunit in supernatants (data not shown), which provided an additional control 310 
indicating the cell lysis, did not occur during these experiments. 311 
 312 
Characterization of B. cenocepacia tyrosine phosphatase mutants 313 
Single gene deletion mutants of BCAM0208, dpm, bceD and BCAL2200 were constructed to 314 
evaluate the contribution of individual LMW-PTPs to B. cenocepacia infectivity in 315 
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macrophages. The genetic background for the construction of the mutants was B. cenocepacia 316 
MH1K, an aminoglycoside sensitive K56-2 mutant strain useful for intracellular infections 317 
(Hamad et al., 2010). No differences in growth rate at 37 or 42 °C were found in the 318 
∆BCAM0208, ∆dpm, ∆bceD and ∆BCAL2200 mutants in comparison to parental MH1K (Fig. 319 
3a). Also, the mutants did not differ in swimming and swarming motility (Fig. 3b), except for 320 
∆bceD, which had a noticeable swarming defect (Fig. 3b). 321 
 322 
∆dpm cannot delay BcCV lysosomal fusion 323 
We have previously reported that the BcCV in infected macrophages has a maturation arrest 324 
demonstrated by failure to acidify and delayed fusion with lysosomes up to 6-8 h post infection 325 
(Huynh et al., 2010; Lamothe et al., 2007; Lamothe & Valvano, 2008). To determinate whether 326 
vacuoles containing B. cenocepacia mutant strains display delayed phagosome maturation we 327 
preloaded macrophages with fluorescein isothiocyanate–dextran overnight prior to infection with 328 
parental and mutant bacteria. At 2 h post infection, BcCVs in ∆dpm infected macrophages 329 
showed significant differences in colocalization with the fluorescein-labelled lysosomes (Fig. 330 
4a). Quantification indicated that 66 ± 2 % of BcCVs containing ∆dpm were dextran positive, 331 
while 40 ± 2 % of BcCVs containing the parental strain colocalized with dextran rich 332 
compartments (p<0.01; Fig. 4b). In contrast, BcCVs of macrophages infected with ∆BCAM0208, 333 
∆bceD and ∆BCAL2200 indicated 27 ± 6 %, 39 ± 4 % and 39 ± 2 % colocalization with dextran 334 
(Fig. 4b). These results suggest that loss of Dpm increases the traffic of BcCVs to the lysosome.  335 
 336 
To further characterize the differential endocytic trafficking observed in macrophages infected 337 
with ∆dpm we compared the accumulation of the lysosome-associated membrane protein 338 
(LAMP-1) on the BcCVs by immunostaining (Fig. 5a). At 2 and 4 h postinfection, 47 ± 3 and 59 339 
± 1.5% of BcCVs containing ∆dpm accumulated LAMP-1, respectively (Fig. 5b). In contrast, 30 340 
± 0.5 and 32 ± 7 % of BcCVs containing the parental strain colocalized with LAMP-1 (Fig. 5b), 341 
respectively, as it has been previously shown for B. cenocepacia strains (Schmerk & Valvano, 342 
2013). LAMP-1 accumulation of ∆dpm BcCVs was restored to parental levels (25 ± 3 % and 45 343 
± 3 % after 2 and 4 h, respectively) by expressing dpm from the pdpm plasmid (Fig. 5a and b). 344 
Together, these results indicate that Dpm contributes to the delayed phagolysosomal fusion in 345 
macrophages infected with B. cenocepacia. 346 
 347 
Dpm is secreted intracellularly upon macrophage infection 348 
We tested whether DpmFLAG is secreted after bacterial internalization by macrophages using 349 
antiserum against B. cenocepacia in combination with monoclonal antibodies against the FLAG 350 
epitope. Macrophages were infected with ∆dpm carrying pdpm (encoding full length Dpm), or 351 
p∆27 (encoding Dpm lacking the predicted leader peptide Table 1). Immunostaining of 352 
macrophages infected with ∆dpm (pdpm) revealed FLAG-specific immunofluorescence at the 353 
periphery of 62.74 ± 2.2 % BcCVs, which overlapped with the localization of B. cenocepacia 354 
(Fig. 6a and b), as expected by a secreted effector able to escape from the phagosome (Bach et 355 
al., 2008). In contrast, only 5.4 ± 0.2 % of FLAG-specific signal was observed colocalizing with 356 
BcCVs of macrophages infected with ∆dpm (p∆27) (Fig. 6a and b), this value can be attributed 357 
to the detergent treatment during permeabilization for immunostaining or even to bacteria cell 358 
lysis. Immunoblot analysis of bacterial lysates revealed that dpm and ∆27dpm were equally 359 
expressed (Fig. 6c, left upper panel), confirming that both proteins are synthesized at similar 360 
levels. We also noticed that ∆27DpmFLAG, which has a predicted mass of 18 kDa, migrated 361 
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slightly above full-length DpmFLAG, which has a predicted mass of 20.9 kDa (Fig. 6c, upper 362 
panel). We interpreted this result as an indication of the presence of uncleaved ∆27DpmFLAG 363 
polypeptide and efficiently processed DpmFLAG. This is supported by the demonstration that 364 
DpmFLAG but not the truncated derivative was detected in the culture supernatants (Fig. 6c, upper 365 
panel). The lack of β-lactamase TEM-1 in the supernatants indicated that the bacteria had an 366 
intact outer membrane leakage (Fig 6c, lower panel). Together, our results indicate that Dpm 367 
requires an N-terminal (signal peptide) for secretion.  368 
 369 
Single LMW-PTPs are not required to B. cenocepacia intramacrophage survival 370 
We also assessed whether the effect of ∆dpm in the acceleration of the BcCV maturation 371 
correlates with decreased intracellular bacterial survival. Gentamicin protection assays of 372 
macrophages infected with ∆BCAM0208, ∆dpm, ∆bceD, and ∆BCAL2200 revealed no 373 
differences in the recovery of intracellular bacteria at 1 h and 24 h post infection in comparison 374 
to the parental strain (Fig. 7). Similar results were also obtained using human THP-1 375 
macrophages (data not shown), a more restrictive cell line to B. cenocepacia infection (Schmerk 376 
& Valvano, 2013). Therefore, none of the LMW-PTPs encoding genes is required for B. 377 
cenocepacia intramacrophage survival. 378 
 379 
Dpm delays maturation of B. multivorans-containing vacuoles (BmCVs) 380 
Unlike B. cenocepacia, B. multivorans strains do not delay phagosomal maturation in murine 381 
macrophages (Schmerk & Valvano, 2013). No homolog to dpm is present in the B. multivorans 382 
ATCC 17616 genome (data not shown). To investigate whether Dpm could alter B. multivorans 383 
trafficking pdpm and pDA17 (vector control) were mobilized into B. multivorans ATCC 17616 384 
GmS (Table 1) and these strains were used in infection experiments. Macrophages were 385 
preloaded with fluorescein isothiocyanate–dextran and subsequently infected with ATCC 17616 386 
GmS (pDA17) or ATCC 17616 GmS (pdpm). At 2 h post infection, 45 ± 0.2% of BmCVs 387 
carrying ATCC 17616 GmS (pdpm) colocalized with fluorescent dextran. In contrast, 388 
colocalization with fluorescent dextran was observed in 74 ± 0.4% of ATCC 17616 GmS 389 
(pDA17) BmCVs (Fig. 8a and b). Furthermore, we confirmed that B. multivorans supports the 390 
secretion of Dpm, as demonstrated by detection of this protein in the supernatant of B. 391 
multivorans at similar levels as found with B. cenocepacia (Fig. 8c). Together, the results of 392 
these experiments strongly support the notion that Dpm is a bacterially secreted protein affecting 393 
phagosomal maturation. 394 
 395 
Dpm lacks phosphatase activity 396 
Despite the absence of a critical Cys for catalysis in its predicted phosphatase motif we 397 
investigated if the Dpm has any phosphatase activity. We constructed inducible plasmids 398 
encoding N- or C-terminal histidine tagged Dpm (pHisdpm and pdpmHis, respectively, since the 399 
position of the histidine tag may alter phosphatase activity (Ueda & Wood, 2009). A plasmid 400 
expressing BCAL2200 carrying an N-terminal 6x-His tag (pHisL2200) was used as a control. 401 
Recombinant proteins were overproduced in E. coli BL21(DE3) and purified by Ni2+-affinity 402 
chromatography (Fig. 9a). A double banded pattern appeared using Dpm-His (carrying a C-403 
terminal His tag), suggesting the purification of both processed and unprocessed forms of Dpm, 404 
which agreed with the predicted masses of 20.9 and 17.9 kDa, respectively (Fig. 9a). In contrast, 405 
the presence of the histidine tag plus 10 additional residues in the Dpm N-terminus blocks 406 
processing of the protein resulting in a polypeptide with an apparent mass of 24 kDa, as expected 407 
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(Fig. 9a). All of the purified proteins were assayed for their ability to cleave the general 408 
phosphatase substrate p-nitrophenyl phosphate (PNPP). Recombinant BCAL2200 efficiently 409 
hydrolyzed the synthetic substrate (Fig. 9b) with an estimated specific activity of 1.44 ± 0.4 410 
nmoles min-1 µg-1, a value that is in the range of that reported for other bacterial LMW-PTPs 411 
(Ferreira et al., 2007; Vincent et al., 1999). However, we could not detect PNPP hydrolysis by 412 
any of the Dpm derivatives under the same conditions used for BCAL2200 or by adding a 10-413 
fold excess of substrate and/or protein into the reaction mix (Fig. 9b and data not shown). We 414 
attempted the reconstruction of the catalytic site by replacing the aspartate at position 36 with 415 
cysteine. The corresponding recombinant proteins His-DpmD36C and Dpm-HisD36C were purified 416 
to homogeneity (Fig. 9a) and assayed for PNPP hydrolysis, but they remained inactive (Fig. 9b). 417 
Together, these experiments indicate that Dpm lacks phosphatase activity, but this is not only 418 
due to the absence of a cysteine at the D36 position (Fig. 9b), suggesting additional mutations in 419 
this protein that alter its putative phosphatase activity. 420 
 421 
 422 
DISCUSSION 423 
 424 
Persistence of B. cenocepacia and other Bcc bacteria within the airways of cystic fibrosis 425 
patients has been associated with their ability to survive intracellularly in macrophages and 426 
epithelial cells (Valvano et al., 2014). We have previously shown abnormal maturation of the 427 
BcCVs in infected macrophages, but very little is known about the mechanism used by 428 
intracellular B. cenocepacia to arrest phagolysosome fusion. In this work, we show that deletion 429 
of dpm accelerates the maturation of the BcCVs in macrophages cells. 430 
 431 
Dpm was initially identified as one member of a group of four predicted LMW-PTPs in B. 432 
cenocepacia. These putative proteins were investigated since bacterial protein tyrosine 433 
phosphatases commonly interfere with host signaling (Whitmore & Lamont, 2012) and could be 434 
candidates for effector proteins mediating the phagosomal maturation arrest in B. cenocepacia-435 
infected macrophages. However, dpm was the only gene whose deletion resulted in loss of the 436 
phagosomal maturation defect in B. cenocepacia-infected macrophages. Several pieces of 437 
evidence support this conclusion: (i) the ∆dpm strain rapidly acquired the lysosomal marker 438 
LAMP-1, a phenotype that was abrogated by restoration of a functional dpm expressed from a 439 
recombinant plasmid; (ii) BcCVs containing ∆dpm bacteria colocalized more rapidly with 440 
dextran rich compartments; and (iii) heterologous expression of dpm in B. multivorans, which 441 
normally traffics rapidly to the lysosome, caused a delay in the traffic of bacteria-containing 442 
vacuoles to the lysosome compartment. Together, these observations indicate that Dpm directly 443 
contributes to the phagosome maturation arrest observed for intracellular B. cenocepacia.  444 
 445 
The role of Dpm as an effector protein is also supported by its ability to be secreted to the culture 446 
supernatant and in macrophages. Indeed, Dpm was the only predicted tyrosine phosphatase that 447 
was secreted both in vitro and also during macrophage infection, as it could be detected at the 448 
periphery of the BcCVs. Deletion experiments revealed that Dpm secretion requires a signal 449 
peptide, suggesting that the protein crosses the inner membrane in a Sec-dependent manner. The 450 
specific mechanism involved in Dpm secretion across the outer membrane remains to be 451 
discovered. Nevertheless, once Dpm is transported outside the bacteria we can hypothesize that it 452 
escapes of the vacuole through the BcCV membrane damage induced via T6SS, in a similar 453 
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manner as has been shown for type II secreted proteins (Rosales-Reyes et al., 2012a). Despite the 454 
relevance of Dpm delaying phagosome maturation, bacterial intramacrophage survival was not 455 
affected in the Δdpm strain suggesting that other factors are required to enable B. cenocepacia 456 
survival in the lysosomes. The trafficking delay in B. cenocepacia is not observed with B. 457 
multivorans although both bacteria can survive in a lysosomal compartment (Schmerk & 458 
Valvano, 2013). This suggests that other factors likely common to both species play a role in 459 
intramacrophage survival. A similar scenario can be anticipated to other Bcc members; however 460 
additional work describing specific intracellular behavior of different Bcc members remains to 461 
be revealed. 462 
 463 
The apparently restricted conservation of dpm to only a few Burkholderia species is puzzling. 464 
This gene in B. cenocepacia is located next to BCAM0627, encoding a putative endonuclease 465 
VII protein that is homologous to gp-49 from the T4 phage, which resolves four-way junctions in 466 
branch DNAs (Jensch & Kemper, 1986). BCAM0627 is predicted to be co-transcribed with 467 
BCAM0626, which encoded a helix-turn-helix protein. Both BCAM0626-BCAM0627 form a 468 
predicted toxin-antitoxin cassette, which is proposed to stabilize heterologous replicons (Dziewit 469 
et al., 2007). Therefore, it is possible that dpm and its neighboring genes may have been acquired 470 
by horizontal transmission, thus explaining their restricted conservation.  471 
 472 
Remarkably, Dpm lacks phosphatase activity and this defect cannot be corrected by 473 
reconstructing the critical catalytic cysteine at the position corresponding to aspartate 36. 474 
However, a highly conserved second cysteine and a proline at positions 41 and 44, respectively, 475 
are also missing in the Dpm predicted phosphatase motif. These residues could also be important 476 
for proper enzymatic activity, since both cysteines of the phosphatase motif may form an 477 
intramolecular disulfide bridge that protects the nucleophilic cysteine from oxidation (Raugei et 478 
al., 2002). Alternatively, other mutations abolishing phosphatase activity appear to stabilize 479 
substrate binding (Bach et al., 2008; Bliska et al., 1992; Mukhopadhyay & Kennelly, 2011; 480 
Murli et al., 2001). Therefore, we speculate that Dpm could potentially recognize and remain 481 
attached to a tyrosine phosphorylated host cell substrate, partially blocking its function. Another 482 
possibility is that Dpm might recognize a non-tyrosine phosphorylated host substrate. For 483 
instance PtpA from M. tuberculosis prevents phagosomal acidification by binding to the H-484 
subunit of the macrophage vacuolar-H+-ATPase, even though subunit H is not a tyrosine-485 
phosphorylated protein (Wong et al., 2011). The region of PtpA required to bind H subunit was 486 
mapped at it C-terminal α-helix and is also independent of the presence of the PtpA catalytic 487 
cysteine (Wong et al., 2011). Unfortunately, attempts to isolate a putative macrophage host cell 488 
substrate for Dpm by pull-down assays, similar to those performed with M. tuberculosis were 489 
unsuccessful (data not shown), and further experiments are underway to elucidate its molecular 490 
mechanism. In summary, our results indicate that Dpm is a novel effector protein contributing to 491 
the ability of B. cenocepacia to subvert the phagocytic pathway in macrophages by a mechanism 492 
that is independent of its predicted phosphatase activity.  493 
 494 
 495 
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Table 1. Strains and plasmids 740 
 741 
aBCRRC, B. cepacia complex Research and Referral Repository for Canadian Cystic Fibrosis Clinics; 742 
Cm, chloramphenicol; Gm, gentamicin; Kan, kanamycin; Tet, tetracycline; Tp, trimethoprim. 743 
744 
Strain or plasmid Relevant characteristicsa Source/reference 
B. cenocepacia   
K56-2 ET12 clone related to J2315, clinical isolate BCRRCa,(Mahenthiraling
am et al., 2000) 
MH1K K56-2, ∆amrABC; GmS (Hamad et al., 2010) 
∆BCAL2200 MH1K, ∆BCAL2200, GmS   This study 
∆BCAM0208 MH1K, ∆BCAM0208, GmS   This study 
∆bceD MH1K, ∆bceD, GmS   This study 
∆dpm MH1K, ∆dpm, GmS   This study 
B. multivorans   
ATCC 17616 Gms ATCC 17616, ∆Bmul_1614-1616, GmS  (Schmerk & Valvano, 
2013) 
E. coli   
BL21(DE3) F− dcm ompT hsdS(rB-,mB-) gal λ(DE3) Stratagene 
DH5α F− ɸ80dlacZ∆M15 ∆(lacZYA-argF)U169 endA1 recA1 
hsdR17(rK− mK+) supE44 thi-1 ∆gyrA96 relA1 
Laboratory stock 
GT115 F− mcrA ∆(mrr-hsdRMS-mcrBC) ɸ80dlacZ∆M15  
∆lacX74 recA1 rspL (StrA) endA1 ∆dcm  
idA(∆MluI)::pir-116 ∆sbcC-sbcD 
Invitrogen 
   
Plasmids   
pDAI-SceI-SacB oripBBR, TetR, Pdhfr, mob+, expressing I-SceI, SacB  (Hamad et al., 2010) 
pDA17 Expression vector, oripBBR1, TetR, mob+, Pdhfr, FLAG 
epitope 
D. Aubert, unpublished 
pET28 Expression vector, oripBBR1, KanR, PT7 Novagen 
pGPI-SceI oriR6K, ΩTpR, mob+, I-SceI restriction site, TpR (Flannagan et al., 2008) 
pIN62 oripBBR mob+, CmR, DSRed (Vergunst et al., 2010) 
pRK2013 oricolE1, RK2 derivative, KanR, mob+, tra+ (Figurski & Helinski, 
1979) 
pDelM0208 pGPI-SceI with fragments flanking the BCAM0208 This study 
pDelM0628 pGPI-SceI with fragments flanking the dpm This study 
pDelM0857 pGPI-SceI with fragments flanking the BCAM0857 This study 
pDelL2200 pGPI-SceI with fragments flanking the BCAL2200 This study 
pbceD pDA17 encoding bceD This study 
Pdpm pDA17 encoding dpm This study 
pL2200 pDA17 encoding BCAL2200 This study 
pM0208 pDA17 encoding BCAM0208 This study 
p∆27 pDA17 encoding dpm without their first 27 codons This study 
pHisL2200 pET28 encoding 6xHis-BCAL2200-FLAG tagged  This study 
pHisdpm pET28 encoding 6xHis-dpm-FLAG tagged This study 
pHisdpm D36C pHisdpm, with the substitution D36C This study 
pdpmHis pET28 encoding dpm-6xHis tagged  This study 
pdpmHis D36C pdpmHis, with the substitution D36C This study 
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Table 2. Oligonucleotides primers 745 
Primer no. 5’–3’ primer sequencea Restriction enzymeb Purpose 
5914 TTTTGAATTCCGAGACAGCAACGGCGTGTA EcoRI Pair to amplify BCAM0208 
upstream region 5915 TTTTCTCGAGGCACACGTTGCCTTCGCAGA XhoI 
5997 TTTTCTCGAGGGCGCTGATCGATCTCGC XhoI Pair to amplify BCAM0208 
downstream region 5998 TTTTTCTAGAGACGAACGCGCCGATCACC XbaI 
5855 TTTTGAATTCGACCAGGAAGTGCTGCTGT EcoRI Pair to amplify dpm upstream 
region 5856 TTTTCTCGAGGACCTTCTTCGGTTCGTC XhoI 
5857 TTTTCTCGAGCCGATCGACTTCTACGAA XhoI Pair to amplify dpm 
downstream region 5858 TTTTTCTAGAGTTCAGCCATTCGGTGAAAG XbaI 
5999 TTTTGAATTCGGTACGAGGTCAAGGAGGT EcoRI Pair to amplify BCAL2200 
upstream region 6000 TTTTCTCGAGAGATGTTGCCGAGACAGACG XhoI 
6001 TTTTCTCGAGGAAGTGGCCGATCCGTATT XhoI Pair to amplify BCAL2200 
downstream region 6002 TTTTTCTAGACACGGATTCGACGATTTCA XbaI 
6003 TTTTGAATTCGCTCGAACGCCTCACCTT EcoRI Pair to amplify bceD 
upstream region 6014 TTTTCATATGGTGCGACTTGAACAGCATT NdeI 
6004 TTTTCATATGGAACGTCTGGTTCAAGGATG NdeI Pair to amplify bceD 
downstream region 6005 TTTTTCTAGAGACCGATTGCGTCGTGTT XbaI 
6006 TTTCATATGAAAAGAAGGCACACC NdeI Forward to dpm 
6007 TTTTCTAGACTGCTTCGCCGGCAC XbaI Reverse to dpm 
6008 TTTCATATGACCCGCGTTGCGATC NdeI Forward to BCAL2200 
6025 ACCGCTGAATACCGTGTCTAGAGCG XbaI Reverse to BCAL2200 
6010 TTTCATATGCCGACCCCGCCCCCG NdeI Forward to BCAM0208 
6011 TTTTCTAGATGACTGGAATCCTGAG XbaI Reverse to BCAM0208 
6012 TTTCATATGTTCCGGAACATCCTG NdeI Forward to bceD 
6013 TTTTCTAGAGCATAGTTTCTGTAG XbaI Reverse to bceD 
6486 TTTCATATGGAACCGAAGAAGGTCGCG NdeI Forward from codon 28 of dpm  
    
6829 TTTCCATGGAAAGAAGGCACACCCTC NcoI Forward to dpm 
6830 TTTCTCGAGCTGCTTCGCCGGCACGG XhoI Reverse to dpm 
6496 AGGTCGCGTTCGTCTGCACGGGCAACACCG N/A Forward to exchange dpm D36C 
6517 CGGTGTTGCCCGTGCAGACGAACGCGACCT N/A Reverse to exchange dpm D36C 
aRestriction endonuclease sites incorporated in the oligonucleotide sequences are underlined. 746 
bN/A indicates the absence of restriction site.    747 
748 
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Figure Legends 749 
Fig. 1. B. cenocepacia J2315 genome encodes 4 predicted LMW-PTPs. (a). Partial ClustalW 750 
sequence alignment of Burkholderia cenocepacia Dpm, BCAM0208, BceD, BCAL2200, 751 
Mycobacterium tuberculosis PtpA (Mtb PtpA), Saccharomyces cerevisiae LTP1 752 
(YEAST_LTP1), Homo sapiens LMWPc (HUMAN_LMWPc), and Sus scrofa LMWPc 753 
(SWINE_LMWPc). Bar indicates the tyrosine phosphatase motif, CX5R(S/T), and the asterisk 754 
denotes the position of the catalytic cysteine. (b) Schematic representation of the genetic 755 
environment around the predicted B. cenocepacia LMW-PTPs (black) and their associated 756 
tyrosine kinases (grey) as annotated in strain J2315. Predicted iron-sulfur metabolism related 757 
genes are marked by an asterisk. Arrows denote the directionality of gene transcription.  758 
 759 
Fig. 2. Secretion of LMW-PTPs into the growth medium. pDA17 derivatives encoding the 760 
various predicted LMW-PTPs were expressed in B. cenocepacia K56-2. Immunodetection of 761 
whole-cell-lysates and secreted proteins was performed using antibodies specific for the FLAG 762 
epitope (α-FLAG) and the beta lactamase of E. coli (α-TEM-1). Molecular masses of protein 763 
standards are indicated. 764 
 765 
Fig. 3. Characterization of single-deletion mutant strains. (a) Growth curves in LB medium at 37 766 
°C (straight lines) and 42 °C (dashed lines). (b) Bacterial motility assays in soft agar at 37 °C. 767 
Graph represents the mean ± SEM from three independent experiments. *** p<0.001 relative to 768 
MH1K (WT).  769 
 770 
Fig. 4. Bacterial colocalization with dextran-rich vacuoles. Pulse-chase experiments were 771 
conducted with RAW264.7 macrophages. Lysosomes were pre-loaded with fluorescein-dextran 772 
and infected with strains expressing the DSRed fluorescent protein. Colocalization was assessed 773 
at 2 h post infection. (a) Immunofluorescence microscopy images of infected macrophages with 774 
MH1K (wild-type) and ∆dpm strains. (b) Quantification of BcCV colocalizing with dextran at 2 775 
h post infection. Graph represents the mean ± SEM from three independent experiments. ** 776 
p<0.01 relative to MH1K (WT).  777 
 778 
Fig. 5. Colocalization of BcCVs with LAMP-1. RAW264.7 macrophages were infected with 779 
MH1K and ∆dpm strains expressing the DSRed fluorescent protein or ∆dpm expressing pdpm. 780 
(a) Colocalization at 2 h post infection. Cells were fixed and immunolabelled using rat anti-781 
LAMP-1 and a secondary antibody conjugated to Alexa Fluor 488. For complementation assays 782 
B. cenocepacia did not express the DSRed encoding plasmid, as it was incompatible with the 783 
complementing plasmids. Therefore bacteria were detected in these cases by antiserum against 784 
K56-2, plus a secondary anti-rabbit antibody conjugated to Alexa Fluor 594. (b) Quantification 785 
of BcCVs colocalizing with LAMP-1 at 2 and 4 h post infection. Graph represents mean ± SEM 786 
from three independent experiments. ** p<0.01 relative to MH1K (WT).  787 
 788 
Fig. 6. Secretion of Dpm during macrophage infection. (a) RAW264.7 macrophages were 789 
infected with ∆dpm carrying the plasmid pdpm or p∆27 and examined for immunolocalization of 790 
the Dpm protein together with B. cenocepacia at 1 h post infection. (b) Quantification of FLAG 791 
colocalizing with BcCV. Graph represents mean ± SEM from three independent experiments. 792 
*** p<0.001 relative to FLAG colocalization of ∆dpm containing pdpm. (c) Secretion assays in 793 
B. cenocepacia expressing pdpm or p∆27. Immunodetection of whole-cell-lysates and secreted 794 
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proteins was performed using antibodies specific for the FLAG epitope (α-FLAG) and the E. coli 795 
β-lactamase (α-TEM-1). Molecular masses of protein standards are indicated. 796 
 797 
Fig. 7. Intramacrophage survival of B. cenocepacia mutants with deletion of LMW-PTPs 798 
encoding genes. Infected macrophages were lysed at 1 or 24 h post infection, and intracellular 799 
bacteria were enumerated by serial dilution and colony counts on LB agar plates. The results 800 
represent the averages and standard errors of three independent experiments. No significant 801 
differences in replication or survival were found using an unpaired t test. 802 
 803 
Fig. 8. Dpm modifies B. multivorans phagosome traffic. (a) Pulse-chase experiments in 804 
RAW264.7 macrophages. Lysosomes were pre-loaded with fluorescein-dextran and infected 805 
with B. multivorans carrying pdpm or the vector pDA17. (b) Quantification of BmCV 806 
colocalization with dextran at 2 h post infection. Graph represents mean ± SEM from three 807 
independent experiments. *** p<0.001 relative to dextran colocalization of B. multivorans 808 
containing pDA17. (c) Immunodetection of Dpm in whole-cell-lysates (P) and supernatants (S) 809 
of B. cenocepacia and B. multivorans carrying pdpm. Detection was performed using antibodies 810 
specific for the FLAG epitope (α-FLAG) and the α subunit of the E. coli RNA polymerase (α-811 
RNAPol) as cell lysis control. Molecular masses of protein standards are indicated at the left of 812 
each panel. 813 
 814 
Fig. 9. Phosphatase activity assay. (a) Coomassie blue-stained SDS-PAGE of purified Dpm and 815 
BCAL2200 recombinant proteins. (b) Phosphatase activity of purified BCAL2200 and Dpm at 816 
37 °C using 1mM PNPP as substrate.  817 
818 
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